![]() Fleg is employed by the National Institutes of Health. O’Meara has received consulting fees from Pfizer, Novartis, and Servier grants from Servier and a research grant from the New England Research Institute via subcontract from the National Institutes of Health. Desai has received consulting fees from Novartis, Boston Scientific, Reata, Cardiomems, 5 am Ventures, Intel, Coverys, and Relypsa and research grants from AtCor Medical to support the Vascular Stiffness Ancillary Study to the TOPCAT trial, for which he is listed as principal investigator. Shah has received consulting fees from the American Board of Internal Medicine, AstraZeneca, DC Devices, Novartis, Bayer, and Alnilam and speaking fees from the Pulmonary Hypertension Association and the American Society of Echocardiography. Shah has received research support from Novartis, Gilead, and Action. ![]() The content of this paper does not necessarily represent the views of the sponsor or of the U.S. TOPCAT was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (Contract No.
0 Comments
Leave a Reply. |